Search

everythinglearnresearchcommunity

for

Search:↓

Birth control pills and anti-androgen medications help manage hair growth, acne, and hair loss in women with PCOS.

Most cases of high male hormone levels in women are due to polycystic ovary syndrome.

The document concludes that blocking the internal pathways that create androgens might help treat cancers that depend on sex hormones.

Diane 35 plus finasteride is more effective in reducing hair growth and androgen levels, but may decrease libido.

Certain genetic variations are linked to increased androgen levels in PCOS, but more research is needed to understand these connections fully.

Overweight women with PCOS are more likely to have excess male hormones.

Metformin works better for adolescent girls with PCOS who have certain genetic variations.

The article suggests renaming Polycystic Ovarian Syndrome (PCOS) to "Hyperandrogenic Persistent Ovulatory Dysfunction Syndrome" (HA-PODS) for accuracy and consistency, but no final decision was made.

Androgen therapy can help with symptoms like low libido in women, but more research is needed to understand its long-term safety and effects on health.

Genetic defects in testosterone production can cause hormonal and developmental disorders, and more research is needed to understand androgen regulation and develop safer treatments.

Two women with very high androgen levels had only slight skin issues, one due to a non-classical adrenal disorder and the other due to an adrenal tumor.

People with PCOS, especially if obese, often have NAFLD, linked to obesity, insulin resistance, and high androgen levels.

The document's conclusion cannot be provided because the document is not accessible or understandable.

Women with PCOS have more depression and stress due to high androgen levels, not obesity or insulin resistance.

The document concludes that accurate measurement of serum androgens is crucial for diagnosing hyperandrogenism.

Doctors should know how to diagnose and treat PCOS, which often involves checking for high male hormone levels and using medications to manage symptoms.

Flutamide, an antiandrogen, has minimal impact on female rat endocrine systems and does not significantly change their reproductive cycles.

The European Society of Endocrinology advises individualized long-term management for PCOS, focusing on lifestyle changes, accurate diagnosis, and treatments for associated health risks and symptoms.

The document concludes that insulin resistance is key in PCOS development and early treatment is crucial to prevent complications.

The document concludes that early recognition and treatment of PCOS in adolescents is crucial for managing symptoms and long-term health risks.

The conclusion is that hirsutism should be diagnosed and treated because it affects quality of life and may signal other health problems.

Insulin-lowering medications show promise for PCOS symptoms but can't be the main treatment yet due to limited long-term research.

Early diagnosis and treatment of PCOS is crucial to reduce emotional distress and health risks.

The conclusion is that young women with excessive hair growth should be quickly tested for hormonal issues and treated to improve their social well-being.

The document explains that hirsutism, often caused by hormonal issues, can be managed with treatment to improve both physical appearance and mental health.

New treatments for PCOS focus on managing symptoms and improving fertility.

Testosterone therapy may improve mood, well-being, and sexual function in premenopausal women, but more research is needed on its long-term safety and effectiveness.

Antiandrogens are the main treatment for hirsutism, with individualized care and safe, affordable options needed.

Most women with hirsutism have it because of PCOS, and they need long-term treatment including medication and hair removal to improve their condition.

Manage PCOS in primary care with weight loss, psychological support, medication, and monitoring for health risks.